Schizophrenia

The term Schizophrenia was coined by the Swiss psychiatrist Eugen Bleuler in 1911, replacing Emil Kraepelin's earlier classification of dementia praecox (premature madness). Bleuler emphasized the fundamental 'splitting' of psychic functions—specifically the dissociation among cognition, emotion, and behavior—rather than inevitable progressive cognitive deterioration. The four fundamental symptoms identified by Bleuler, known historically as Bleuler's Four A's, are Associations (loosening of thought), Affect (blunted or inappropriate emotional expression), Ambivalence (holding conflicting feelings simultaneously), and Autism (withdrawal from reality into an inner fantasy world).

• Positive Symptoms (Excesses/Distortions): Reflect an addition of abnormal behaviors and perceptions, including hallucinations (false sensory experiences without external stimuli, most commonly auditory), delusions (fixed, false beliefs impervious to reason, such as persecutory, grandiose, or referential delusions), disorganized thinking (manifested as loosening of associations, tangentiality, or word salad), and grossly disorganized or abnormal motor behavior (including catatonia).
• Negative Symptoms (Deficits): Reflect a reduction or absence of normal behaviors and functions, including Alogia (poverty of speech), Avolition (decrease in motivated self-initiated purposeful activities), Anhedonia (inability to experience pleasure from previously rewarding activities), Asociality (lack of interest in social interactions), and Affective Flattening (reduced emotional expression).
• DSM-5 Diagnostic Criteria: Requires the presence of two or more core symptoms (delusions, hallucinations, disorganized speech, grossly disorganized/catatonia, negative symptoms) during a 1-month period (or less if successfully treated), with continuous signs of the disturbance persisting for at least 6 months, accompanied by marked social or occupational dysfunction.

Schizophrenia is understood through a multifactorial biopsychosocial lens, primarily driven by genetic vulnerability and neurodevelopmental abnormalities. The genetic contribution is robust; twin and adoption studies (e.g., Gottesman's family risk studies) demonstrate that the lifetime risk increases proportionally to genetic relatedness, rising to roughly 50% for monozygotic twins and 10% for first-degree relatives.

• The Dopamine Hypothesis: Classical psychopharmacology established that positive symptoms of schizophrenia are associated with hyperactive dopaminergic transmission in the mesolimbic pathway, while negative and cognitive symptoms are linked to hypoactive dopaminergic activity in the mesocortical pathway. Traditional neuroleptics (e.g., chlorpromazine, haloperidol) block postsynaptic dopamine D2 receptors, whereas atypical antipsychotics (e.g., clozapine, risperidone) modulate both dopamine and serotonin (5-HT2A) receptors.
• Neuroanatomical Correlates: Advanced neuroimaging reveals structural brain abnormalities, notably ventricular enlargement (enlargement of the lateral and third ventricles) reflecting neuronal atrophy or loss of neuropil, alongside reduced volume in the prefrontal cortex, temporal lobes, and hippocampus.
• The Neurodevelopmental Hypothesis: Proposes that subtle disruptions in early brain development—stemming from genetic mutations, obstetrical complications, prenatal viral infections (e.g., influenza during the second trimester), or nutritional deprivation—lay a dormant neuropathological foundation that interacts with environmental stressors during adolescence or early adulthood to trigger overt symptom onset.

While neurobiological factors initiate vulnerability, psychosocial and environmental variables significantly influence the course, relapse rates, and recovery trajectories of individuals with schizophrenia.

• The Diathesis-Stress Model: Integrates biological predisposition (diathesis) with environmental stressors (such as high urban density, migration, trauma, or dysfunctional family dynamics). A seminal psychosocial construct in this domain is Expressed Emotion (EE)—characterized by high levels of criticism, hostility, and emotional over-involvement by family members—which significantly increases the probability of psychotic relapse.
• Cognitive Behavioral Therapy for Psychosis (CBTp): Developed to target residual psychotic symptoms by challenging cognitive distortions, examining the evidence for delusions, and reframing the interpretation of auditory hallucinations to reduce distress and behavioral compliance.
• ICD-11 vs. DSM-5 Shifts: The World Health Organization's ICD-11 has streamlined schizophrenia subtypes (such as paranoid, hebephrenic, and catatonic), moving away from rigid categorical subtypes toward dimensional symptom ratings (e.g., negative symptom severity, cognitive symptoms, depressive symptoms) to capture individual clinical complexity more accurately.